Genetic Variations and Coronary Microvascular Dysfunction
Author Information
Author(s): Tian Dingyuan, Li Jie, Lai Xiaoyue, Yang Qingyuan, Zhang Zhihui, Deng Fang
Primary Institution: Chongqing Medical University
Hypothesis
Single nucleotide polymorphisms (SNPs) can serve as reliable genetic markers for the early diagnosis and targeted intervention of coronary microvascular dysfunction (CMD).
Conclusion
The review highlights the potential of SNPs in improving the diagnosis and treatment of CMD, despite the current limitations in understanding its pathogenesis.
Supporting Evidence
- CMD affects a significant percentage of patients with myocardial ischemia and no obstructive arteries.
- Genetic factors play a crucial role in the development of coronary artery disease.
- Identifying SNPs can lead to personalized therapies and improved patient outcomes.
Takeaway
Scientists are studying tiny changes in our genes to help find and treat a heart problem called coronary microvascular dysfunction, which can make it hard for blood to flow to the heart.
Methodology
This review summarizes existing research on CMD-associated SNPs and their potential therapeutic implications.
Limitations
The studies on CMD-related SNPs are limited and relatively new, indicating a need for further research.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website